Company Overview and News


Add AUP
to your dashboard

Headline News

Aurinia Pharmaceuticals' (AUPH) CEO Richard Glickman on Q3 2017 Results - Earnings Call Transcript

2017-11-15 seekingalpha
Greetings and welcome to the Aurinia Pharmaceuticals Incorporated Third Quarter 2017 Financial Results. At this time, all participants are in listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. (247-4)

Is a Surprise Coming for Aurinia Pharmaceuticals (AUPH) This Earnings Season?

2017-11-13 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Aurinia Pharmaceuticals Inc. (AUPH - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Aurinia Pharmaceuticals is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. (247-6)

Daily Coverage on Healthcare Stocks, Oncolytics Biotech, Aurinia Pharma, Immunovaccine, and IntelliPharmaCeutics International

2017-11-08 accesswire
LONDON, UK / ACCESSWIRE / November 8, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Biotechnology industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics International. (268-4)

Park Hotels' Yield Is Good - Cramer's Lightning Round (11/3/17)

2017-11-06 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, November 3. (248-3)

Cramer Remix: Wait to hear Nvidia’s earnings before buying the stock

2017-11-03 cnbc
CNBC's Jim Cramer told investors to hang on to the stock market's "benign" action on Friday ahead of another potentially raucous week of earnings. (291-0)

Cramer's lightning round: I'm concerned about GameStop

2017-11-03 cnbc
GameStop Corp.: "I am concerned about GameStop. I have to tell you, if they're going to sell EA down and they're going to sell Activision Blizzard down… It's going to be a very digital holiday season, and to me, that means that's bad for GameStop, so I'm going to have to say don't buy." (286-0)

AUPH / Aurinia Pharmaceuticals Inc - Stock Institutional Ownership and Shareholders - Fintel.io

2017-10-23 fintel.io
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has 69 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,973,973 shares. Largest shareholders include FMR LLC / Fidelity Management & Research, Duggan Robert W, NEA Management Company, LLC, Orbimed Advisors Llc, and Franklin Resources Inc. (279-15)

The Vision Is Clear: Listen To Merck And Invest In Microcap KalVista Pharmaceuticals

2017-10-18 seekingalpha
KalVista remains under $100M market cap despite huge partnership with Merck which included $37M upfront cash and 10% ownership stake (366-9)

Aurinia Pharmaceuticals: An Under $10 Biotech Stock To Keep An Eye On

2017-10-16 seekingalpha
Phase 2b AURA-LV study yields positive clinical outcome in patients with Lupus Nephritis using Voclosporin as treatment. (285-14)

Aurinia Pharmaceuticals (AUPH) Looks Good: Stock Adds 7.8% in Session

2017-10-16 zacks
Aurinia Pharmaceuticals Inc. (AUPH - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $6.10–$7.09 in the past one-month time frame, witnessed a sharp increase yesterday. (266-3)

Should You Buy Progressive Corporation (PGR) Ahead of Earnings?

2017-10-16 zacks
Investors are always looking for stocks that are poised to beat at earnings season and The Progressive Corporation (PGR - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. (248-1)

Is Marathon Petroleum (MPC) Stock a Solid Choice Right Now?

2017-10-16 zacks
One stock that might be an intriguing choice for investors right now is Marathon Petroleum Corporation (MPC - Free Report) . This is because this security in the Oil and Gas - Refining and Marketing space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. (249-0)

Options Traders Expect Huge Moves in Popular (BPOP) Stock

2017-10-16 zacks
Investors in Popular, Inc. (BPOP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 20th 2017 $41.00 Put had some of the highest implied volatility of all equity options today. (258-0)

Phillips 66 (PSX): Strong Industry, Solid Earnings Estimate Revisions

2017-10-16 zacks
One stock that might be an intriguing choice for investors right now is Phillips 66 (PSX - Free Report) . This is because this security in the Oil and Gas - Refining and Marketing space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. (249-0)

Bunge (BG) Jumps: Stock Rises 6.8%

2017-10-16 zacks
Bunge Limited (BG - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $67.18–$72.49 in the past one-month time frame, witnessed a sharp increase yesterday. (278-1)